Starpharma (ASX:SPL) compound shows activity against coronavirus
15 April 2020 Starpharma’s antiviral dendrimer, SPL7013, has been shown to have significant activity against SARS-CoV-2[1] (coronavirus), which causes COVID-19 SPL7013 is the active component in Starpharma’s range of marketed VivaGel® products[2] (VivaGel® BV and the VivaGel® condom), already sold in Australia, UK, Europe,…
PharmAust and Walter and Eliza Hall Institute to Evaluate Monepantel on COVID-19 Infection Model
17 April 2020 PharmAust has entered into a Materials Transfer Agreement with the Walter and Eliza Hall Institute of Medical Research in Melbourne, Victoria (“WEHI”). Under the Agreement, PharmAust will provide both monepantel and monepantel sulfone to WEHI,…
Our wicked problem and the pursuit of a new normal
16 April 2020 Ms Gouri Betigeri, Country Manager ANZ, Life Science, Clarivate On 30 March 2020, Prime Minister Scott Morrison announced that the Commonwealth Government will roll out a $130 billion wage subsidy program, called the JobKeeper Payment…
Australian Medtech Startup Made It To The Finals In The World’s Largest COVID-19 Hackathon
16 April 2020 ‘3 Billion People in Lockdown. Let’s Hack The Future and Never Go Through This Again’ – the slogan of a world renowned online hackathon called ‘The Global Hack’. MedTech Startup MUVi made it into the…
Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19
15 April 2020 Sanofi and GSK today announce that they have signed a letter of intent to enter into a collaboration to develop an adjuvanted vaccine for COVID-19, using innovative technology from both companies, to help address…
Working From Home Security
16 April 2020 In coming to grips with the new, and hopefully not for too long, normal of working remotely, we continue to receive many requests for guidance on protecting one’s cyber security when working from home. …
Ventilator Manufacturers Unite to Form Ventilator Training Alliance and Create App to Help Frontline Medical Workers During COVID-19 Pandemic
15 April 2020 Medtronic and other leading ventilator manufacturers have joined to form the Ventilator Training Alliance (VTA). The VTA announced the launch of its app this morning. The alliance is an industry-wide effort to provide healthcare professionals…
Novavax to commence COVID-19 vaccine trial with Nucleus Network
15 April 2020 US-based clinical-stage biotechnology company Novavax (NASDAQ: NVAX) has called upon the expertise of Australian based Nucleus Network (Nucleus) to commence Phase 1 clinical trials for its COVID-19 vaccine trials. As part of the urgent global…
Cancer diagnostic companies Sienna and BARD1 announce merger
14 April 2020 (Announced 8 April 2020) The merger of Sienna Cancer Diagnostics Ltd (“Sienna”, ASX:SDX) and BARD1 Life Sciences Limited (“BARD1”, ASX:BD1) will create a well-resourced, Australian-based cancer diagnostics company with a global presence. The combined entity…
NHMRC gives $2m for COVID-19 research in areas of urgent need
13 April 2020 The National Health and Medical Research Council (NHMRC) will provide an additional $2m of funding for COVID-19 research that will generate maximum benefits for the Australian public. The funding is for nine critical COVID-19 research projects as…
New virus in bats linked to AIDS-like disease decimating koalas
14 April 2020 Devastated by summer’s unprecedented firestorms, Australia’s koalas are facing a potentially more serious and enduring existential threat from a fellow mammal – the bat. A new collaborative study led by Burnet Institute and CSIRO scientists…
Burnet’s COVID-19 self-isolation study
14 April 2020 Understanding people’s experiences and needs and ability to successfully self-isolate for COVID-19 is the goal of a new Burnet Institute study to inform current and future pandemic response. Led by Professor Margaret Hellard AM, the…
